A Response to: Letter to the Editor Regarding “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”

This communication seeks to address the questions of Dhere and colleagues in their letter on our study “Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine (PCV13) versus lower-valent alternatives in Filipino infants.” We hope to provide clarity on each of the three potential misunder...

Descripción completa

Detalles Bibliográficos
Autores principales: Perdrizet, Johnna, Horn, Emily K., Nua, Winniefer, Perez-Peralta, Judith, Nailes, Jennifer, Santos, Jaime, Ong-Lim, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124259/
https://www.ncbi.nlm.nih.gov/pubmed/35474191
http://dx.doi.org/10.1007/s40121-022-00639-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124259/
https://www.ncbi.nlm.nih.gov/pubmed/35474191
http://dx.doi.org/10.1007/s40121-022-00639-3

Ejemplares similares